Medline Inc. (MDLN)

Medline Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	1,266	1,200	234	-25
Depreciation & Amortization	1,003	977	951	933
Other Amortization	60	57	80	85
Loss (Gain) From Sale of Assets	6	6	11	6
Stock-Based Compensation	60	61	78	64
Provision & Write-off of Bad Debts	91	63	8	29
Other Operating Activities	137	80	124	14
Change in Accounts Receivable	-388	-256	-153	-376
Change in Inventory	-601	-545	444	-195
Change in Accounts Payable	65	106	136	-103
Change in Other Net Operating Assets	-257	20	-228	-245
Operating Cash Flow	1,442	1,769	1,685	187
Operating Cash Flow Growth	-14.42%	4.98%	801.07%	-
Capital Expenditures	-433	-364	-285	-254
Cash Acquisitions	-	-1,126	-16	-17
Investment in Securities	-	-	-11	7
Other Investing Activities	-	-3	-	-
Investing Cash Flow	-433	-1,493	-312	-264
Short-Term Debt Issued	-	166	-	80
Long-Term Debt Issued	-	15,932	-	-
Total Debt Issued	14,035	16,098	-	80
Short-Term Debt Repaid	-	-166	-	-80
Long-Term Debt Repaid	-	-15,995	-77	-61
Total Debt Repaid	-14,104	-16,161	-77	-141
Net Debt Issued (Repaid)	-69	-63	-77	-61
Repurchase of Common Stock	-34	-20	-	-
Common Dividends Paid	-1,781	-1,518	-114	-23
Other Financing Activities	-8	-12	-	-
Financing Cash Flow	-1,892	-1,613	-191	-84
Foreign Exchange Rate Adjustments	22	2	4	-30
Net Cash Flow	-861	-1,335	1,186	-191
Free Cash Flow	1,009	1,405	1,400	-67
Free Cash Flow Growth	-27.93%	0.36%	-	-
Free Cash Flow Margin	3.68%	5.51%	6.03%	-0.31%
Free Cash Flow Per Share	0.06	0.08	0.08	-
Cash Interest Paid	958	1,022	1,126	800
Cash Income Tax Paid	101	101	52	54
Levered Free Cash Flow	-	772	-	-
Unlevered Free Cash Flow	-	1,430	-	-
Change in Working Capital	-1,181	-675	199	-919

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q